Keywords: درمان های هدفمند; siRNA; Liposomes; Nanovectors; Delivery; Cancer; Gene silencing; Targeted therapies
مقالات ISI ترجمه شده درمان های هدفمند
مقالات ISI درمان های هدفمند (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: درمان های هدفمند; Anti-PD-1/PD-L1; Immunotherapy; Immune checkpoint inhibitors; mRCC; Targeted therapies;
Keywords: درمان های هدفمند; Immunotherapies; monoclonal antibodies; small molecule inhibitors; targeted therapies;
Keywords: درمان های هدفمند; chronic lymphocytic leukemia; CLL; primary care; targeted therapies; tumor biology;
Keywords: درمان های هدفمند; chronic lymphocytic leukemia; CLL; primary care; targeted therapies; tumor biology;
Keywords: درمان های هدفمند; ABC; ATP-binding cassette; ASBT; apical sodium-dependent bile acid transporter; Bamet-UD2; cisplatin-ursodeoxycholic acid derivative; CCA; cholangiocarcinoma; DHMEQ; dehydroxymethyl epoxyquinomicin; EGFR; epidermal growth factor receptor; 5-FU; 5-fluorour
Keywords: درمان های هدفمند; Systemic Lupus Erythematosus; Treatment; Targeted therapies; Clinical trials; Systematic review;
Keywords: درمان های هدفمند; Breast cancer; PET imaging; Radiotracer; Tumor proliferation; Targeted therapies;
Keywords: درمان های هدفمند; Non-small cell lung cancer; Radiotherapy; Targeted therapies; Immunotherapies;
Keywords: درمان های هدفمند; Breast cancer; Bone metastases; Osteolysis; Osteoblastic lesions; Osteomimicry; Targeted therapies;
Keywords: درمان های هدفمند; DLBCL; diffuse large B-cell lymphoma; R-CHOP; rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone; NHL; non-Hodgkin lymphoma; GEP; gene expression profiling; COO; cell-of-origin; GCB; germinal center B-cell; ABC; activated B-cell; PMBL;
Keywords: درمان های هدفمند; Gastric cancer; Elderly; Early-stage disease; Adjuvant; Metastatic; Targeted therapies;
Keywords: درمان های هدفمند; Molecular screening; Targeted therapies; Next-generation sequencing; Primary tumour; Metastases;
Keywords: درمان های هدفمند; Cancer bronchique; Concertation multidisciplinaire; Médecine personnalisée; Traitements ciblés; Lung cancer; Molecular tumor board; Personalized medicine; Targeted therapies;
Keywords: درمان های هدفمند; Leiomyosarcoma; Uterine sarcoma; Uterine morcellation; Rare tumor; Targeted therapies;
Keywords: درمان های هدفمند; Brain metastases; Genomics; Targeted therapies; Sequencing;
Keywords: درمان های هدفمند; Chromophobe RCC; Papillary RCC; Rare histologic subtypes; Renal cell carcinoma; Targeted therapies;
Keywords: درمان های هدفمند; Melanoma; miRNA; Cytokines; Targeted therapies; Immunotherapy;
Keywords: درمان های هدفمند; Melanoma; Brain metastasis; Gamma-Knife radiosurgery; Check-point inhibitors; Targeted therapies;
Keywords: درمان های هدفمند; Pancreatic Cancer; Tumor microenvironment; Stroma; Targeted therapies; miRNAS;
Keywords: درمان های هدفمند; Inflammation; Endothelial cells; Angiogenesis; Immune regulation; Endothelial-to-mesenchymal transition (EndMT); Targeted therapies;
Keywords: درمان های هدفمند; Mucosal melanoma; Head and neck; Surgery; Radiotherapy; Targeted therapies; c-KIT immunotherapies; anti PD-1/PD-L1;
Keywords: درمان های هدفمند; Liver Cancer; Molecular Drivers; Targeted Therapies; Prognosis; CLC; cholangiolocellular carcinoma; FLC; fibrolamellar hepatocellular carcinoma; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; HCC-CCA; mixed hepatocellular cholangiocarcinoma; HCV;
Keywords: درمان های هدفمند; Chemotherapy; immunotherapy; non-small cell lung cancer; radiotherapy; small cell lung cancer; surgery; targeted therapies
Keywords: درمان های هدفمند; Kidney cancer; Clear cell renal carcinoma; Prognosis factors; Glandular metastases; Survival outcome; Targeted therapies; Antiangiogenic therapy;
Keywords: درمان های هدفمند; Digestive neuroendocrine neoplasms; mTOR pathway; Prognostic factors; Targeted therapies;
Keywords: درمان های هدفمند; Allogeneic stem cell transplantation; Leukocytosis; Targeted therapies; Tyrosine kinase inhibitors
Keywords: درمان های هدفمند; Clinical trial design; Adaptive trial design; Biomarker-based design; Bayesian adaptive design; Enrichment designs; Targeted therapies
Keywords: درمان های هدفمند; Targeted therapies; Dermatologic adverse events; Quality of life;
Keywords: درمان های هدفمند; gastric cancer; targeted therapies; HER2; tyrosine kinase receptors
Keywords: درمان های هدفمند; Segmentation; Neuro-oncology; Radiation oncology; High-grade glioma treatment; Targeted therapies
Keywords: درمان های هدفمند; Small cell lung cancer; Targeted therapies; Precision medicine; Molecular analysis; Angiogenesis; Cell signalling; Apoptosis; Immunotherapies; DNA repair; Antibody-drug conjugate;
Keywords: درمان های هدفمند; Pancreatic Neuroendocrine Tumor (PanNET); Gastrointestinal neuroendocrine tumors; Foregut; Targeted therapies; Pancreas surgery;
Keywords: درمان های هدفمند; Melanoma; Chemoradiation; Chemotherapy; Radiotherapy; Radiosensitivity; Preoperative; Targeted therapies;
Keywords: درمان های هدفمند; Chemotherapy; Genetics; MBC; Review; Targeted therapies;
Keywords: درمان های هدفمند; Thymomas; Thymic carcinoma; Diagnosis; Surgery; Radiotherapy; Chemotherapy; Targeted therapies;
Keywords: درمان های هدفمند; Therapeutic resistance; Targeted therapies; Broad-spectrum; Phytochemicals
Keywords: درمان های هدفمند; Kidney cancer; Renal clear cell carcinoma; Metastases; Nephrectomy; Metastasectomy; Targeted therapies
Keywords: درمان های هدفمند; Squamous cell carcinoma of the penis; Lymphovascular invasion; Epithelial-to-mesenchymal transition; Immunohistochemistry; Cadherin switch; Targeted therapies;
Keywords: درمان های هدفمند; IMDC risk model; Kidney cancer; Overall survival; Prognostication; Targeted therapies;
Keywords: درمان های هدفمند; Absorption; affinity; bioavailability; biomarkers; cancer; clinical pharmacology; disposition; drug interactions; efficacy pharmacodynamics; pharmacogenomics; pharmacokinetics; potency; receptors; targeted therapies; transporters
Keywords: درمان های هدفمند; GIST; Leiomyosarcoma; Small bowel; Signaling pathways; Surgery; Targeted therapies
Keywords: درمان های هدفمند; Locally advanced non-small-cell lung cancer; Concomitant chemo-radiotherapy; Radiotherapy; Targeted therapies; Immunotherapy; Proton radiotherapy
Keywords: درمان های هدفمند; Targeted therapies; Drug regulation; Benefit-risk balance;
Keywords: درمان های هدفمند; Lymph node metastases; Lymph nodes; Targeted therapies; Treatment response; Survival outcome; Renal cell carcinoma;
Keywords: درمان های هدفمند; Targeted therapies; Membrane receptor inhibitors; Gynecological malignancies
Keywords: درمان های هدفمند; Bladder cancer; BCAN; Think Tank; Targeted therapies; Sexual dysfunction; Gender disparities; Working groups;
Keywords: درمان های هدفمند; Bladder cancer; Urothelial carcinoma; Signaling pathways; Tumorigenesis; Treatment; Targeted therapies
Keywords: درمان های هدفمند; Molecular Classification; Genomic Profiling; Outcome; Targeted Therapies; CI; confidence interval; CNV; copy number variations; EGFR; epidermal growth factor receptor; EpCAM; epithelial cellular adhesion molecule; FDR; false discovery rate; FF; fresh-froz
Keywords: درمان های هدفمند; Non-small cell lung cancer; Targeted therapies; Early-stage; Locally-advanced stage